Analyzing SI-BONE (NASDAQ:SIBN) and Quipt Home Medical (NASDAQ:QIPT)

Quipt Home Medical (NASDAQ:QIPTGet Free Report) and SI-BONE (NASDAQ:SIBNGet Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership.

Volatility & Risk

Quipt Home Medical has a beta of 0.62, meaning that its stock price is 38% less volatile than the S&P 500. Comparatively, SI-BONE has a beta of 1.22, meaning that its stock price is 22% more volatile than the S&P 500.

Earnings & Valuation

This table compares Quipt Home Medical and SI-BONE”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Quipt Home Medical $221.74 million 0.48 -$2.78 million ($0.11) -22.27
SI-BONE $157.04 million 3.30 -$43.34 million ($0.92) -13.43

Quipt Home Medical has higher revenue and earnings than SI-BONE. Quipt Home Medical is trading at a lower price-to-earnings ratio than SI-BONE, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

42.9% of Quipt Home Medical shares are owned by institutional investors. Comparatively, 98.1% of SI-BONE shares are owned by institutional investors. 4.2% of Quipt Home Medical shares are owned by insiders. Comparatively, 3.9% of SI-BONE shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Quipt Home Medical and SI-BONE’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Quipt Home Medical -1.95% -4.51% -2.01%
SI-BONE -23.82% -22.51% -16.53%

Analyst Recommendations

This is a summary of current ratings and price targets for Quipt Home Medical and SI-BONE, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quipt Home Medical 1 0 3 2 3.00
SI-BONE 0 0 6 0 3.00

Quipt Home Medical presently has a consensus price target of $6.25, indicating a potential upside of 155.10%. SI-BONE has a consensus price target of $23.00, indicating a potential upside of 86.08%. Given Quipt Home Medical’s higher probable upside, research analysts clearly believe Quipt Home Medical is more favorable than SI-BONE.

Summary

Quipt Home Medical beats SI-BONE on 9 of the 14 factors compared between the two stocks.

About Quipt Home Medical

(Get Free Report)

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

About SI-BONE

(Get Free Report)

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.